Given that the altered analytes in serum and CSF related to LRRK2 mutations and PD were largely non-overlapping or had an inverse relationship, we analyzed the correlation between serum analytes and CSF analytes in the subset of matching serum and CSF samples using the Spearman correlation coefficient. The gene discussed is LRRK2; the disease is Parkinson disease.